𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Papillary Thyroid Carcinoma in Mexican Patients: Clinical Aspects and Prognostic Factors

✍ Scribed by Miguel F. Herrera; Carlos M. López-Graniel; Jorge Saldaña; Armando Gamboa-Domínguez; Yvonne Richaud-Patín; Florencia Vargas-Vorackova; Arturo Angeles-Angeles; Luis Llorente; Cecilia Castillo; Bernardo Pérez; Raúl Rivera; Ofelia González; Juan Rull

Publisher
Springer
Year
1996
Tongue
English
Weight
245 KB
Volume
20
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors in papillary carcinom
Prognostic factors in papillary carcinoma of the thyroid
✍ Anne-Marie Schindler; Guy van Melle; Beatrice Evequoz; Bianca Scazziga 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

In a retrospective study of 119 patients, followed for 1 to 30 years after treatment of a papillary carcinoma of the thyroid, the authors searched for possible prognostic factors of the risk of recurrence. Microcarcinomas, anaplastic tumors and Hürthle cell carcinomas were excluded from the study. I

Pure versus follicular variant of papill
Pure versus follicular variant of papillary thyroid carcinoma : Clinical features, prognostic factors, treatment, and survival
✍ Jamal Zidan; Drumea Karen; Moshe Stein; Edward Rosenblatt; Walid Basher; Abraham 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The follicular variant of papillary thyroid carcinoma (FVPTC) is a common subtype of papillary thyroid carcinoma. Few studies have compared the clinical behavior and treatment outcome of patients with FVPTC with the outcome of patients with pure papillary carcinoma (PTC).

Prognostic factors in patients with recu
Prognostic factors in patients with recurrent differentiated thyroid carcinoma
✍ Asakawa, Hideki; Kobayashi, Tetsuro; Komoike, Yoshifumi; Tamaki, Yasuhiro; Matsu 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 3 views

Background: Approximately 20% of patients with thyroid carcinoma have relapse. To evaluate the factors affecting their disease-free survival and prognosis, we studied 68 patients with recurrent differentiated thyroid carcinoma, ranging in age from 5 to 73 years (mean: 47.6 years). Threefourths of pa